| # | Drug | Count |
|---|---|---|
| 0 | PEMBROLIZUMAB | 9 |
| 1 | DOXYCYCLINE | 8 |
| 2 | DOXYCYCLINE HYCLATE | 8 |
| 3 | METHOTREXATE SODIUM | 8 |
| 4 | IBUPFROFEN | 7 |
| 5 | IBUPROFEN | 7 |
| 6 | IBUPROFEN 200 MG | 7 |
| 7 | IBUPROFEN 200MG | 7 |
| 8 | IBUPROFEN CAPSULE | 7 |
| 9 | IBUPROFEN CAPSULES 200 MG | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BEPOTASTINE BESILATE | 1 | 0.0016 |
| 1 | WHITE PETROLATUM | 1 | 0.0007 |
| 2 | PIMECROLIMUS | 1 | 0.0006 |
| 3 | BETAMETHASONE DIPROPIONATE | 2 | 0.0003 |
| 4 | ESOMEPRAZOLE MAGNESIUM DIHYDRATE | 2 | 0.0001 |
| 5 | ENFORTUMAB VEDOTIN | 1 | 0.0001 |
| 6 | DOXYCYCLINE HYCLATE | 8 | 0.0001 |
| 7 | DOXYCYCLINE | 8 | 0.0001 |
| 8 | DASPONE | 1 | 0.0001 |
| 9 | DAPSONE GEL, 5% | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 13 | 0.0001 |
| 1 | Tetracycline-class Drug [EPC] | 8 | 0.0001 |
| 2 | Sulfone [EPC] | 1 | 0.0001 |
| 3 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 4 | Angiotensin Converting Enzyme Inhibitor [EPC] | 5 | 0.0000 |
| 5 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 6 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Interleukin-17A Antagonist [EPC] | 1 | 0.0000 |
| 8 | CTLA-4-directed Blocking Antibody [EPC] | 1 | 0.0000 |
| 9 | Aminosalicylate [EPC] | 2 | 0.0000 |